Skip to main content

Alto Neuroscience, Inc.

For the period ended Jun 30, 2026. Filed Aug 12, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 12, 2026

ANRO$25.16+15.0%Stored close · as of Nov 6, 2026
Opening this filing…